Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), left, and Martin Makary, commissioner of the Food and Drug Administration (FDA), in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mike Doustdar, chief executive officer of Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

A man faints as US President Donald Trump gives remarks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mike Doustdar, chief executive officer of Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Representative Tom Emmer, a Republican from Minnesota, from left, US President Donald Trump, and Heidi Overton, White House domestic policy council, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Martin Makary, commissioner of the Food and Drug Administration (FDA), in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, from left, David Ricks, chief executive officer of Eli Lilly & Co., and Martin Makary, commissioner of the Food and Drug Administration (FDA), in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

David Moore, executive vice president of US Operations at Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Heidi Overton, White House domestic policy council, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Chris Klomp, deputy administrator of the Centers for Medicare and Medicaid, speaks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, speaks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump applauds in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Donald Trump Announces Drug Pricing Deal With Pharma Giants - DC

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

Howard Lutnick, US commerce secretary, and US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

Martin Makary, commissioner of the Food and Drug Administration (FDA), in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

Mike Doustdar, chief executive officer Novo Nordisk A/S, from left, David Ricks, chief executive officer of Eli Lilly & Co., and Howard Lutnick, US commerce secretary, stand behind US President Donald Trump in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), speaks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

Mike Doustdar, chief executive officer Novo Nordisk A/S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

US President Donald Trump speaks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

US President Donald Trump, center, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

US President Donald Trump speaks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

US President Donald Trump speaks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

US President Donald Trump speaks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

Trump Speaks in The Oval Office - Washington

US President Donald Trump speaks in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. Photo by Aaron Schwartz/Pool/ABACAPRESS.COM

E

White House

Centers for Medicare and Medicaid Services Administrator Mehmet Oz speaks during an annoucement about in vitro fertilization in the Oval Office at the White House Oct. 16, 2025. Photo by Francis Chung/Pool/ABACAPRESS.COM

E

US President Donald Trump announces a drug pricing deal during a press conference in the Oval Office

US President Donald Trump, with Secretary of Commerce Howard Lutnick (L), AstraZeneca CEO Pascal Soriot (2-L), Virginia Governor Glenn Youngkin (3-L), Administrator of the Centers for Medicare & Medicaid Services Dr. Mehmet Oz (3-R), Secretary of Health and Human Services Robert F Kennedy Jr (2-R), delivers closing remarks following the announcement of a drug pricing deal during a press conference in the Oval Office of the White House in Washington, DC, USA, 10 October 2025. The deal, made with AstraZeneca CEO Pascal Soriot, includes deep price cuts for the Medicaid health plans and discounted prices through the TrumpRx website opening next year.

E

US President Donald Trump announces a drug pricing deal during a press conference in the Oval Office

US President Donald Trump, with Virginia Governor Glenn Youngkin (L), AstraZeneca CEO Pascal Soriot (2-L) and Administrator of the Centers for Medicare & Medicaid Services Dr. Mehmet Oz (R), deliver remarks during the announcement of a drug pricing deal during a press conference in the Oval Office of the White House in Washington, DC, USA, 10 October 2025. The deal, made with AstraZeneca CEO Pascal Soriot, includes deep price cuts for the Medicaid health plans and discounted prices through the TrumpRx website opening next year.

E

US President Donald Trump announces a drug pricing deal during a press conference in the Oval Office

US President Donald Trump, with Virginia Governor Glenn Youngkin (L), AstraZeneca CEO Pascal Soriot (2-L) and Administrator of the Centers for Medicare & Medicaid Services Dr. Mehmet Oz (R), deliver remarks during the announcement of a drug pricing deal during a press conference in the Oval Office of the White House in Washington, DC, USA, 10 October 2025. The deal, made with AstraZeneca CEO Pascal Soriot, includes deep price cuts for the Medicaid health plans and discounted prices through the TrumpRx website opening next year.

E

US President Donald Trump announces a drug pricing deal during a press conference in the Oval Office

US President Donald Trump, with Virginia Governor Glenn Youngkin (L), AstraZeneca CEO Pascal Soriot (2-L) and Administrator of the Centers for Medicare & Medicaid Services Dr. Mehmet Oz (R), deliver remarks during the announcement of a drug pricing deal during a press conference in the Oval Office of the White House in Washington, DC, USA, 10 October 2025. The deal, made with AstraZeneca CEO Pascal Soriot, includes deep price cuts for the Medicaid health plans and discounted prices through the TrumpRx website opening next year.

E

US President Donald Trump announces a drug pricing deal during a press conference in the Oval Office

Administrator of the Centers for Medicare & Medicaid Services Dr. Mehmet Oz delivers remarks during the announcement of a drug pricing deal at a press conference in the Oval Office of the White House in Washington, DC, USA, 10 October 2025. The deal, made with AstraZeneca CEO Pascal Soriot, includes deep price cuts for the Medicaid health plans and discounted prices through the TrumpRx website opening next year.

E

White House

Centers for Medicare and Medicaid Services Administrator Mehmet Oz speaks during an announcement on using artificial intelligence to treat childhood cancer in the Oval Office at the White House Sept. 30, 2025. Photo by Francis Chung/Pool/ABACAPRESS.COM

E

White House

President Donald Trump speaks alongside, from left, Vice President JD Vance, Director of Medicare and Deputy Administrator of CMS Chris Klomp, Pfizer CEO Albert Bourla, Health and Human Services Secretary Robert F. Kennedy Jr., Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary announce a drug-pricing deal with Pfizer in the Oval Office at the White House Sept. 30, 2025. Photo by Francis Chung/Pool/ABACAPRESS.COM

E

White House

Centers for Medicare and Medicaid Services Administrator Mehmet Oz, President Donald Trump, and Food and Drug Administration Commissioner Marty Makary take part in the announcement of a drug-pricing deal with Pfizer in the Oval Office at the White House Sept. 30, 2025. Photo by Francis Chung/Pool/ABACAPRESS.COM

E

White House

Director of Medicare and Deputy Administrator of CMS Chris Klomp takes part in an announcement of a drug-pricing deal with Pfizer in the Oval Office at the White House Sept. 30, 2025. Photo by Francis Chung/Pool/ABACAPRESS.COM

E

White House

From left, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, Pfizer CEO Albert Bourla, President Donald Trump, and Food and Drug Administration Commissioner Marty Makary announce a drug-pricing deal in the Oval Office at the White House Sept. 30, 2025. Photo by Francis Chung/Pool/ABACAPRESS.COM